×

Detection of implantable lead failures by differential EGM analysis

  • US 10,195,420 B2
  • Filed: 11/07/2016
  • Issued: 02/05/2019
  • Est. Priority Date: 06/13/2013
  • Status: Active Grant
First Claim
Patent Images

1. An automated method of diagnosing an anomaly in an implantable lead of an implantable cardioverter defibrillator (ICD) attached to a single-coil defibrillation lead that includes conductors connected to a first low-voltage electrode and a second low-voltage electrode and a high-voltage coil electrode, comprising:

  • monitoring electrogram (EGM) signals from a Reference EGM defined by a pathway between the first and the second low-voltage electrodes through the conductors in the implantable lead and a Diagnostic EGM defined by a pathway between the high-voltage coil electrode and the first low-voltage electrode through conductors in the implantable lead;

    automatically determining valid ventricular events in the Reference EGM;

    automatically comparing the Diagnostic EGM with the Reference EGM to determine if noncardiac signals other than valid ventricular events are present on the Diagnostic EGM; and

    in response to the presence of noncardiac signals other than valid ventricular events on the Diagnostic EGM, automatically initiating one or more responses selected from the group consisting of;

    initiating one or more additional diagnostic tests to confirm that the electrode responsible for the noncardiac signals shorts the defibrillation pathway,initiating a patient alert, andinitiating a remote-monitoring alert.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×